Expression of VEGF-A is an attractive potential marker of prognosis owing to its consistent upregulation in cancer (Carmeliet, 2000), including melanoma (Bayko et al, 1998; Bayer-Garner et al, 1999), but there are conflicting data surrounding the prognostic implication of any observed upregulation. The gene discussed is VEGFA; the disease is melanoma.